PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: New carriers for gene delivery

Biomacromolecules

Volumn 6, Issue 1, 2005, Pages 271-278

  Csaba, Noémi ^a   Caamaño, Pilar ^b   Sánchez, Alejandro ^a   Domínguez, Fernando ^b   Alonso, María José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CELL CULTURE; COMPOSITE MATERIALS; COMPOSITION; DERIVATIVES; DNA; ELECTROPHORESIS; EMULSIFICATION; GENES; NANOSTRUCTURED MATERIALS; POLYETHYLENE GLYCOLS;

GENE DELIVERY; POLOXAMER; POLOXAMINE; POLY(LACTIC-CO-GLYCOLIC ACID) (PLGA);

POLYMER BLENDS;

NANOPARTICLE; PLASMID DNA; POLOXAMER; POLYGLACTIN;

ARTICLE; CELL CULTURE; CELL VIABILITY; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EMULSION; ENCAPSULATION; GEL ELECTROPHORESIS; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL SURVIVAL; DNA; DRUG CARRIERS; ETHYLENEDIAMINES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LACTIC ACID; MOLECULAR STRUCTURE; NANOSTRUCTURES; PLASMIDS; POLOXAMER; POLYGLYCOLIC ACID; POLYMERS;

EID: 14044266772     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm049577p     Document Type: Article

References (40)

1. Lengsfeld, C. S.; Manning, M. C.; Randolph, T. W. Curr. Pharm. Biotech. 2002, 3, 227-235.
2. Ohada, H.; Heya, T.; Ogawa, Y.; Shimamoto, T. J. Pharmacol. Exp. Ther. 1988, 244, 744-750.
3. Jones, D. H.; Corris, S.; MacDonald, S.; Clegg, J. C. S.; Farrar, G. H. Vaccine 1997, 15, 8, 814-817.
4. Hedley, M. L.; Curley, J.; Urban, R. Nature Med. 1998, 4, 3, 365-368.
5. Panyam, J.; Zhou, W.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V. FASEB J. 2002, 16, 1217-1226.
6. Cohen, H.; Levy, R. J.; Gao, J.; Fishbein, I.; Kousaev, V.; Sosnowski, S.; Slomkowski, S.; Golomb, G. Gene Ther. 2000, 7, 1896-1905.
7. Prabha, S.; Zhou, W.; Panyam, J.; Labhasetwar, V. Int. J. Pharm. 2002, 244, 105-115.
8. Prabha, S.; Labhasetwar, V. Pharm. Res. 2004, 21, 2, 354-364.
9. Lengsfeld, C. S.; Anchordoquy, T. J. J. Pharm. Sci. 2002, 91, 7, 1581-1589.
10. Kuo, J. S.; Jan, M.; Sung, K. C. Int. J. Pharm. 2003 257, 75-84.
11. Middaugh, C. R.; Evans, R. K.; Montgomery, D. L.; Casimiro, D. R. J. Pharm. Sci. 1998, 87, 2, 130-146.
12. Fu, K.; Pack, D. W.; Klibanov, A. M.; Langer, R. Pharm. Res. 2000, 17, 1, 100-106.
13. Ando, S.; Putnam, D.; Pack, D. W.; Langer, R. J. Pharm. Sci. 1999, 88, 1, 126-130.
14. Walter, E.; Moelling, K.; Pavlovic, J.; Merkle, H. P. J. Controlled Release 1999, 61, 361-374.
15. Capan, Y.; Woo, B. H.; Gebredikan, S.; Ahmed, S.; DeLuca, P. J. Controlled Release 1999, 60, 279-286.
16. Lemieux, P.; Guérin, N.; Paradis, G.; Proulx, R.; Chistyakova, L.; Kabanov, V. A.; Alakhov, V. Gene Ther. 2000, 7, 986-991.
17. Prokop, A.; Kozlov, E.; Moore, W.; Davidson, J. M. J. Pharm. Sci. 2002, 91, 1, 67-76.
18. Tobio, M.; Nolley, J.; Guo, y.; McIver, J.; Alonso, M. J. Pharm. Res. 1999, 16, 5, 682-688.
19. Sanchez, A.; Tobio, M.; Gonzalez, L.; Fabra, A.; Alonso, M. J. Eur. J. Pharm. Sci. 2003, 18, 221-229.
20. Csaba, N.; Gonzalez, L.; Sanchez, A.; Alonso, M. J. J. Biomater. Sci., Polym. Ed. 2004, 15, 9, 1137-1151.
21. Vila, A.; Sanchez, A.; Perez, C.; Alonso, M. J. Polym. Adv. Technol. 2002, 13, 851-858.
22. Alonso, M. J. Biomed. Pharmacother. 2004, 58 168-172.
23. Perez, C.; Sanchez, A.; Putnam, D.; Ting, D.; Langer, R.; Alonso, M. J. J. Controlled Release 2001, 75, 211-224.
24. Hsu, Y.; Hao, T.; Hedley, M. L. J. Drug Target. 1999 7, 4, 313-323.
25. Liu, Y.; Deng, X. J. Controlled Release 2002, 83, 147-155.
26. Gopferich, A.; Gref, R.; Minamitake, Y.; Shieh, L.; Alonso, M. J.; Tabata, Y.; Langer, R. Drug delivery from bioerodible polymers ACS Symposium Series 567; American Chemical Society: Washington, DC, 1994; Vol. 15, pp 242-277.
27. Blanco, D.; Alonso, M. J. Eur. J. Pharm. Biopharm. 1998, 45, 285-294.
28. Sanchez, A.; Villamayor, B.; Guo, Y.; McIver, J.; Alonso, M. J. Int. J. Pharm. 1999, 185, 255-266.
29. Yeh, M.; Davis, S. S.; Coombes, A. G. A. Pharm. Res. 1996, 13, 11, 1693-1698.
30. Park, T. G.; Cohen, S.; Langer, R. Pharm. Res. 1992 9, 1, 37-39.
31. Park, T. G.; Cohen, S.; Langer, R. Macromolecules 1992, 25, 116-122.
32. Zhu, G.; Mallery, S. R.; Schwendeman, S. P. Nat. Biotechnol. 2000, 18, 52-57.
33. Wang, D.; Robinson, D. R.; Kwon, G. S.; Samuel, J. J. Controlled Release 1999, 57, 9-18.
34. Walter, E.; Dreher, D.; Kok, M.; Thiele, L.; Kiama, S. G.; Gehr, P.; Merkle, H. P. J. Controlled Release 2001, 76, 149-168.
35. Jong, Y. S.; Jacob, J. S.; Yip, K.; Gardner, G.; Seitelman, E.; Whitney, M.; Montgomery, S.; Mathiovitz, E. J. Controlled Release 1997, 47, 123-134.
36. Perrin, D. E.; English, J. P. In Handbook of biodegradable polymers; Harwood Acad. Publ.: Chichester, U.K., 1997; Vol. 1, pp 3-27.
37. Walter, E.; Merkle, H. P. J. Drug Target. 2002, 10, 1, 11-21.
38. Kabanov, V. A.; Alakhov, V. Crit. Rev. Ther. Drug 2002, 19, 1, 1-73.
39. Kirillova, G. P.; Mokhova, E. N.; Dedukhova, V. I.; Tarakanova, A. N.; Ivanova, V. P.; Efremova, N. V.; Topchieva, I. N. Biotechnol. Appl. Biochem. 1993, 18, 329-339.
40. Goodwin, C. J.; Holt, S. J.; Downes, S.; Marshall, N. J. J. Immunol. Methods 1995, 179, 1, 95-103.